Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 3 November 2000:
Vol. 290. no. 5493, pp. 985 - 989
DOI: 10.1126/science.290.5493.985

Reports

Oxidative Damage Linked to Neurodegeneration by Selective alpha -Synuclein Nitration in Synucleinopathy Lesions

Benoit I. Giasson,1* John E. Duda,1* Ian V. J. Murray,1 Qiping Chen,3 José M. Souza,3 Howard I. Hurtig,2 Harry Ischiropoulos,3 John Q. Trojanowski,1 Virginia M. -Y. Lee1dagger

Aggregated alpha -synuclein proteins form brain lesions that are hallmarks of neurodegenerative synucleinopathies, and oxidative stress has been implicated in the pathogenesis of some of these disorders. Using antibodies to specific nitrated tyrosine residues in alpha -synuclein, we demonstrate extensive and widespread accumulations of nitrated alpha -synuclein in the signature inclusions of Parkinson's disease, dementia with Lewy bodies, the Lewy body variant of Alzheimer's disease, and multiple system atrophy brains. We also show that nitrated alpha -synuclein is present in the major filamentous building blocks of these inclusions, as well as in the insoluble fractions of affected brain regions of synucleinopathies. The selective and specific nitration of alpha -synuclein in these disorders provides evidence to directly link oxidative and nitrative damage to the onset and progression of neurodegenerative synucleinopathies.

1 Center for Neurodegenerative Disease Research and Department of Pathology and Laboratory Medicine,
2 Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104, USA.
3 Stokes Research Institute and Department of Biochemistry and Biophysics, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA 19104, USA.
*   These authors contributed equally to this work.

dagger    To whom correspondence should be addressed. E-mail: vmylee{at}mail.med.upenn.edu


Read the Full Text



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Peroxidase Mechanism of Lipid-dependent Cross-linking of Synuclein with Cytochrome c: PROTECTION AGAINST APOPTOSIS VERSUS DELAYED OXIDATIVE STRESS IN PARKINSON DISEASE.
H. Bayir, A. A. Kapralov, J. Jiang, Z. Huang, Y. Y. Tyurina, V. A. Tyurin, Q. Zhao, N. A. Belikova, I. I. Vlasova, A. Maeda, et al. (2009)
J. Biol. Chem. 284, 15951-15969
   Abstract »    Full Text »    PDF »
Nitrated {alpha}-Synuclein-Induced Alterations in Microglial Immunity Are Regulated by CD4+ T Cell Subsets.
A. D. Reynolds, D. K. Stone, R. L. Mosley, and H. E. Gendelman (2009)
J. Immunol. 182, 4137-4149
   Abstract »    Full Text »    PDF »
Bacterial Artificial Chromosome Transgenic Mice Expressing a Truncated Mutant Parkin Exhibit Age-Dependent Hypokinetic Motor Deficits, Dopaminergic Neuron Degeneration, and Accumulation of Proteinase K-Resistant {alpha}-Synuclein.
X.-H. Lu, S. M. Fleming, B. Meurers, L. C. Ackerson, F. Mortazavi, V. Lo, D. Hernandez, D. Sulzer, G. R. Jackson, N. T. Maidment, et al. (2009)
J. Neurosci. 29, 1962-1976
   Abstract »    Full Text »    PDF »
Mitochondrial Complex I Inhibitor Rotenone Inhibits and Redistributes Vesicular Monoamine Transporter 2 via Nitration in Human Dopaminergic SH-SY5Y Cells.
M. Watabe and T. Nakaki (2008)
Mol. Pharmacol. 74, 933-940
   Abstract »    Full Text »    PDF »
Intermittent hypoxia has organ-specific effects on oxidative stress.
J. Jun, V. Savransky, A. Nanayakkara, S. Bevans, J. Li, P. L. Smith, and V. Y. Polotsky (2008)
Am J Physiol Regulatory Integrative Comp Physiol 295, R1274-R1281
   Abstract »    Full Text »    PDF »
Neuroinflammation and Oxidation/Nitration of {alpha}-Synuclein Linked to Dopaminergic Neurodegeneration.
H.-M. Gao, P. T. Kotzbauer, K. Uryu, S. Leight, J. Q. Trojanowski, and V. M.-Y. Lee (2008)
J. Neurosci. 28, 7687-7698
   Abstract »    Full Text »    PDF »
Conversion of Tyrosine to the Inflammation-Associated Analog 3'-Nitrotyrosine at Either TCR- or MHC-Contact Positions Can Profoundly Affect Recognition of the MHC Class I-Restricted Epitope of Lymphocytic Choriomeningitis Virus Glycoprotein 33 by CD8 T Cells.
L. L. Hardy, D. A. Wick, and J. R. Webb (2008)
J. Immunol. 180, 5956-5962
   Abstract »    Full Text »    PDF »
Transgenic Mice Overexpressing Tyrosine-to-Cysteine Mutant Human {alpha}-Synuclein: A PROGRESSIVE NEURODEGENERATIVE MODEL OF DIFFUSE LEWY BODY DISEASE.
W. Zhou, J. B. Milder, and C. R. Freed (2008)
J. Biol. Chem. 283, 9863-9870
   Abstract »    Full Text »    PDF »
Oxidative Modification of Peroxiredoxin Is Associated with Drug-induced Apoptotic Signaling in Experimental Models of Parkinson Disease.
Y. M. Lee, S. H. Park, D.-I. Shin, J.-Y. Hwang, B. Park, Y.-J. Park, T. H. Lee, H. Z. Chae, B. K. Jin, T. H. Oh, et al. (2008)
J. Biol. Chem. 283, 9986-9998
   Abstract »    Full Text »    PDF »
{alpha}-Synuclein Aggregates Interfere with Parkin Solubility and Distribution: ROLE IN THE PATHOGENESIS OF PARKINSON DISEASE.
K. Kawahara, M. Hashimoto, P. Bar-On, G. J. Ho, L. Crews, H. Mizuno, E. Rockenstein, S. Z. Imam, and E. Masliah (2008)
J. Biol. Chem. 283, 6979-6987
   Abstract »    Full Text »    PDF »
Induction of the Phase II Detoxification Pathway Suppresses Neuron Loss in Drosophila Models of Parkinson's Disease.
K. Trinh, K. Moore, P. D. Wes, P. J. Muchowski, J. Dey, L. Andrews, and L. J. Pallanck (2008)
J. Neurosci. 28, 465-472
   Abstract »    Full Text »    PDF »
S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease.
J. Fang, T. Nakamura, D.-H. Cho, Z. Gu, and S. A. Lipton (2007)
PNAS 104, 18742-18747
   Abstract »    Full Text »    PDF »
Cellular Oligomerization of {alpha}-Synuclein Is Determined by the Interaction of Oxidized Catechols with a C-terminal Sequence.
J. R. Mazzulli, M. Armakola, M. Dumoulin, I. Parastatidis, and H. Ischiropoulos (2007)
J. Biol. Chem. 282, 31621-31630
   Abstract »    Full Text »    PDF »
Clinical, Genetic, and Pathologic Characteristics of Patients With Frontotemporal Dementia and Progranulin Mutations.
V. M. Van Deerlin, E. M. Wood, P. Moore, W. Yuan, M. S. Forman, C. M. Clark, M. Neumann, L. K. Kwong, J. Q. Trojanowski, V. M.-Y. Lee, et al. (2007)
Arch Neurol 64, 1148-1153
   Abstract »    Full Text »    PDF »
Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease.
C. Perier, J. Bove, D.-C. Wu, B. Dehay, D.-K. Choi, V. Jackson-Lewis, S. Rathke-Hartlieb, P. Bouillet, A. Strasser, J. B. Schulz, et al. (2007)
PNAS 104, 8161-8166
   Abstract »    Full Text »    PDF »
An Orally Active Catalytic Metalloporphyrin Protects against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Neurotoxicity In Vivo.
L.-P. Liang, J. Huang, R. Fulton, B. J. Day, and M. Patel (2007)
J. Neurosci. 27, 4326-4333
   Abstract »    Full Text »    PDF »
Involvement of Oxidative Stress on Corneal Epithelial Alterations in a Blink-Suppressed Dry Eye.
S. Nakamura, M. Shibuya, H. Nakashima, R. Hisamura, N. Masuda, T. Imagawa, M. Uehara, and K. Tsubota (2007)
Invest. Ophthalmol. Vis. Sci. 48, 1552-1558
   Abstract »    Full Text »    PDF »
Disposition of Protein-bound 3-nitrotyrosine in Rat Plasma Analysed by a Novel Protocol for HPLC-ECD.
Y. H. Hitomi, J. Okuda, H. Nishino, Y. Kambayashi, Y. Hibino, K. Takemoto, T. Takigawa, H. Ohno, N. Taniguchi, and K. Ogino (2007)
J. Biochem. 141, 495-502
   Abstract »    Full Text »    PDF »
Biphasic Coupling of Neuronal Nitric Oxide Synthase Phosphorylation to the NMDA Receptor Regulates AMPA Receptor Trafficking and Neuronal Cell Death.
G. A. Rameau, D. S. Tukey, E. D. Garcin-Hosfield, R. F. Titcombe, C. Misra, L. Khatri, E. D. Getzoff, and E. B. Ziff (2007)
J. Neurosci. 27, 3445-3455
   Abstract »    Full Text »    PDF »
Aggregated {alpha}-Synuclein Mediates Dopaminergic Neurotoxicity In Vivo.
M. Periquet, T. Fulga, L. Myllykangas, M. G. Schlossmacher, and M. B. Feany (2007)
J. Neurosci. 27, 3338-3346
   Abstract »    Full Text »    PDF »
Cortical biochemistry in MCI and Alzheimer disease: Lack of correlation with clinical diagnosis.
M. S. Forman, E. J. Mufson, S. Leurgans, D. Pratico, S. Joyce, S. Leight, V. M.-Y. Lee, and J. Q. Trojanowski (2007)
Neurology 68, 757-763
   Abstract »    Full Text »    PDF »
Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain.
A. Eslamboli, M. Romero-Ramos, C. Burger, T. Bjorklund, N. Muzyczka, R. J. Mandel, H. Baker, R. M. Ridley, and D. Kirik (2007)
Brain 130, 799-815
   Abstract »    Full Text »    PDF »
A Classification Scheme for Redox-Based Modifications of Proteins.
M. T. Forrester and J. S. Stamler (2007)
Am. J. Respir. Cell Mol. Biol. 36, 135-137
   Full Text »    PDF »
Identification of Immunoglobulins that Recognize 3-Nitrotyrosine in Patients with Acute Lung Injury after Major Trauma.
L. Thomson, J. Christie, C. Vadseth, P. N. Lanken, X. Fu, S. L. Hazen, and H. Ischiropoulos (2007)
Am. J. Respir. Cell Mol. Biol. 36, 152-157
   Abstract »    Full Text »    PDF »
Nitric Oxide and Peroxynitrite in Health and Disease.
P. Pacher, J. S. Beckman, and L. Liaudet (2007)
Physiol Rev 87, 315-424
   Abstract »    Full Text »    PDF »
Dyrk1A Phosphorylates {alpha}-Synuclein and Enhances Intracellular Inclusion Formation.
E. J. Kim, J. Y. Sung, H. J. Lee, H. Rhim, M. Hasegawa, T. Iwatsubo, D. S. Min, J. Kim, S. R. Paik, and K. C. Chung (2006)
J. Biol. Chem. 281, 33250-33257
   Abstract »    Full Text »    PDF »
Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies..
M. R. Reynolds, J. F. Reyes, Y. Fu, E. H. Bigio, A. L. Guillozet-Bongaarts, R. W. Berry, and L. I. Binder (2006)
J. Neurosci. 26, 10636-10645
   Abstract »    Full Text »    PDF »
Cytosolic Catechols Inhibit {alpha}-Synuclein Aggregation and Facilitate the Formation of Intracellular Soluble Oligomeric Intermediates.
J. R. Mazzulli, A. J. Mishizen, B. I. Giasson, D. R. Lynch, S. A. Thomas, A. Nakashima, T. Nagatsu, A. Ota, and H. Ischiropoulos (2006)
J. Neurosci. 26, 10068-10078
   Abstract »    Full Text »    PDF »
Metabolism of 3-nitrotyrosine induces apoptotic death in dopaminergic cells..
B. Blanchard-Fillion, D. Prou, M. Polydoro, D. Spielberg, E. Tsika, Z. Wang, S. L. Hazen, M. Koval, S. Przedborski, and H. Ischiropoulos (2006)
J. Neurosci. 26, 6124-6130
   Abstract »    Full Text »    PDF »
Peroxynitrite Generation and Tyrosine Nitration in Defense Responses in Tobacco BY-2 Cells.
S. Saito, A. Yamamoto-Katou, H. Yoshioka, N. Doke, and K. Kawakita (2006)
Plant Cell Physiol. 47, 689-697
   Abstract »    Full Text »    PDF »
Detection of sequence-specific tyrosine nitration of manganese SOD and SERCA in cardiovascular disease and aging.
S. Xu, J. Ying, B. Jiang, W. Guo, T. Adachi, V. Sharov, H. Lazar, J. Menzoian, T. V. Knyushko, D. Bigelow, et al. (2006)
Am J Physiol Heart Circ Physiol 290, H2220-H2227
   Abstract »    Full Text »    PDF »
The pathogenesis of cell death in Parkinson's disease.
P. Jenner and C. W. Olanow (2006)
Neurology 66, S24-S36
   Abstract »    Full Text »
Proteasomal dysfunction in sporadic Parkinson's disease.
K. St. P. McNaught, T. Jackson, R. JnoBaptiste, A. Kapustin, and C. W. Olanow (2006)
Neurology 66, S37-S49
   Abstract »    Full Text »
CSF amyloid-{beta}-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia.
M. Bibl, B. Mollenhauer, H. Esselmann, P. Lewczuk, H.-W. Klafki, K. Sparbier, A. Smirnov, L. Cepek, C. Trenkwalder, E. Ruther, et al. (2006)
Brain 129, 1177-1187
   Abstract »    Full Text »    PDF »
Reactive Oxygen Species-Mediated Mitochondria-to-Nucleus Signaling: A Key to Aging and Radical-Caused Diseases.
P. Storz (2006)
Sci. STKE 2006, re3
   Abstract »    Full Text »    PDF »
Small Ubiquitin-like Modifier (SUMO) Modification of Natively Unfolded Proteins Tau and {alpha}-Synuclein.
V. Dorval and P. E. Fraser (2006)
J. Biol. Chem. 281, 9919-9924
   Abstract »    Full Text »    PDF »
Pathological Changes in Dopaminergic Nerve Cells of the Substantia Nigra and Olfactory Bulb in Mice Transgenic for Truncated Human {alpha}-Synuclein(1-120): Implications for Lewy Body Disorders.
G. K. Tofaris, P. Garcia Reitbock, T. Humby, S. L. Lambourne, M. O'Connell, B. Ghetti, H. Gossage, P. C. Emson, L. S. Wilkinson, M. Goedert, et al. (2006)
J. Neurosci. 26, 3942-3950
   Abstract »    Full Text »    PDF »
Convergence of Heat Shock Protein 90 with Ubiquitin in Filamentous {alpha}-Synuclein Inclusions of {alpha}-Synucleinopathies.
K. Uryu, C. Richter-Landsberg, W. Welch, E. Sun, O. Goldbaum, E. H. Norris, C.-T. Pham, I. Yazawa, K. Hilburger, M. Micsenyi, et al. (2006)
Am. J. Pathol. 168, 947-961
   Abstract »    Full Text »    PDF »
Parkinson's Disease {alpha}-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death.
L. J. Martin, Y. Pan, A. C. Price, W. Sterling, N. G. Copeland, N. A. Jenkins, D. L. Price, and M. K. Lee (2006)
J. Neurosci. 26, 41-50
   Abstract »    Full Text »    PDF »
Similar Patterns of Mitochondrial Vulnerability and Rescue Induced by Genetic Modification of {alpha}-Synuclein, Parkin, and DJ-1 in Caenorhabditis elegans.
R. Ved, S. Saha, B. Westlund, C. Perier, L. Burnam, A. Sluder, M. Hoener, C. M. P. Rodrigues, A. Alfonso, C. Steer, et al. (2005)
J. Biol. Chem. 280, 42655-42668
   Abstract »    Full Text »    PDF »
Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity.
W. W. Smith, H. Jiang, Z. Pei, Y. Tanaka, H. Morita, A. Sawa, V. L. Dawson, T. M. Dawson, and C. A. Ross (2005)
Hum. Mol. Genet. 14, 3801-3811
   Abstract »    Full Text »    PDF »
Molecular pathogenesis of Parkinson's disease.
S. Gandhi and N. W. Wood (2005)
Hum. Mol. Genet. 14, 2749-2755
   Abstract »    Full Text »    PDF »
Nitric oxide mediates increased susceptibility to dopaminergic damage in Nurr1 heterozygous mice.
S. Z. Imam, J. Jankovic, S. F. Ali, J. T. Skinner, W. Xie, O. M. Conneely, and W.-D. Le (2005)
FASEB J 19, 1441-1450
   Abstract »    Full Text »    PDF »
Proteolytic Cleavage of Extracellular Secreted {alpha}-Synuclein via Matrix Metalloproteinases.
J. Y. Sung, S. M. Park, C.-H. Lee, J. W. Um, H. J. Lee, J. Kim, Y. J. Oh, S.-T. Lee, S. R. Paik, and K. C. Chung (2005)
J. Biol. Chem. 280, 25216-25224
   Abstract »    Full Text »    PDF »
A Precipitating Role for Truncated {alpha}-Synuclein and the Proteasome in {alpha}-Synuclein Aggregation: IMPLICATIONS FOR PATHOGENESIS OF PARKINSON DISEASE.
C.-W. Liu, B. I. Giasson, K. A. Lewis, V. M. Lee, G. N. DeMartino, and P. J. Thomas (2005)
J. Biol. Chem. 280, 22670-22678
   Abstract »    Full Text »    PDF »
{alpha}-Synuclein Phosphorylation Enhances Eosinophilic Cytoplasmic Inclusion Formation in SH-SY5Y Cells.
W. W. Smith, R. L. Margolis, X. Li, J. C. Troncoso, M. K. Lee, V. L. Dawson, T. M. Dawson, T. Iwatsubo, and C. A. Ross (2005)
J. Neurosci. 25, 5544-5552
   Abstract »    Full Text »    PDF »
Reversible Inhibition of {alpha}-Synuclein Fibrillization by Dopaminochrome-mediated Conformational Alterations.
E. H. Norris, B. I. Giasson, R. Hodara, S. Xu, J. Q. Trojanowski, H. Ischiropoulos, and V. M.-Y. Lee (2005)
J. Biol. Chem. 280, 21212-21219
   Abstract »    Full Text »    PDF »
Protein Nitration in a Mouse Model of Familial Amyotrophic Lateral Sclerosis: POSSIBLE MULTIFUNCTIONAL ROLE IN THE PATHOGENESIS.
F. Casoni, M. Basso, T. Massignan, E. Gianazza, C. Cheroni, M. Salmona, C. Bendotti, and V. Bonetto (2005)
J. Biol. Chem. 280, 16295-16304
   Abstract »    Full Text »    PDF »
Metal-catalyzed Oxidation of {alpha}-Synuclein: HELPING TO DEFINE THE RELATIONSHIP BETWEEN OLIGOMERS, PROTOFIBRILS, AND FILAMENTS.
N. B. Cole, D. D. Murphy, J. Lebowitz, L. Di Noto, R. L. Levine, and R. L. Nussbaum (2005)
J. Biol. Chem. 280, 9678-9690
   Abstract »    Full Text »    PDF »
Oxidative Stress in Transgenic Mice with Oligodendroglial {alpha}-Synuclein Overexpression Replicates the Characteristic Neuropathology of Multiple System Atrophy.
N. Stefanova, M. Reindl, M. Neumann, C. Haass, W. Poewe, P. J. Kahle, and G. K. Wenning (2005)
Am. J. Pathol. 166, 869-876
   Abstract »    Full Text »    PDF »
Aggregation promoting C-terminal truncation of {alpha}-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations.
W. Li, N. West, E. Colla, O. Pletnikova, J. C. Troncoso, L. Marsh, T. M. Dawson, P. Jakala, T. Hartmann, D. L. Price, et al. (2005)
PNAS 102, 2162-2167
   Abstract »    Full Text »    PDF »
Multiple pathologies in a patient with a progressive neurodegenerative syndrome.
T-W Liang, M S Forman, J E Duda, L McCluskey, J Q Trojanowski, and A Siderowf (2005)
J. Neurol. Neurosurg. Psychiatry 76, 252-255
   Abstract »    Full Text »    PDF »
Failure to Find {alpha}-Synuclein Gene Dosage Changes in 190 Patients With Familial Parkinson Disease.
S. Gispert, C. Trenkwalder, L. Mota-Vieira, V. Kostic, and G. Auburger (2005)
Arch Neurol 62, 96-98
   Abstract »    Full Text »    PDF »
Functional Consequences of {alpha}-Synuclein Tyrosine Nitration: DIMINISHED BINDING TO LIPID VESICLES AND INCREASED FIBRIL FORMATION.
R. Hodara, E. H. Norris, B. I. Giasson, A. J. Mishizen-Eberz, D. R. Lynch, V. M.-Y. Lee, and H. Ischiropoulos (2004)
J. Biol. Chem. 279, 47746-47753
   Abstract »    Full Text »    PDF »
Biological significance of nitric oxide-mediated protein modifications.
A. J. Gow, C. R. Farkouh, D. A. Munson, M. A. Posencheg, and H. Ischiropoulos (2004)
Am J Physiol Lung Cell Mol Physiol 287, L262-L268
   Abstract »    Full Text »    PDF »
Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) Is a Binding Partner of Epithelial Growth Factor-containing Fibulin-like Extracellular Matrix Protein 1 (EFEMP1): IMPLICATIONS FOR MACULAR DEGENERATIONS.
P. A. Klenotic, F. L. Munier, L. Y. Marmorstein, and B. Anand-Apte (2004)
J. Biol. Chem. 279, 30469-30473
   Abstract »    Full Text »    PDF »
Proteomic Analysis of the Soluble Fraction from Human Corneal Fibroblasts with Reference to Ocular Transparency.
H. Karring, I. B. Thogersen, G. K. Klintworth, J. J. Enghild, and T. Moller-Pedersen (2004)
Mol. Cell. Proteomics 3, 660-674
   Abstract »    Full Text »    PDF »
Hsp70 Reduces {alpha}-Synuclein Aggregation and Toxicity.
J. Klucken, Y. Shin, E. Masliah, B. T. Hyman, and P. J. McLean (2004)
J. Biol. Chem. 279, 25497-25502
   Abstract »    Full Text »    PDF »
{alpha}-Internexin Is Present in the Pathological Inclusions of Neuronal Intermediate Filament Inclusion Disease.
N. J. Cairns, V. Zhukareva, K. Uryu, B. Zhang, E. Bigio, I. R.A. Mackenzie, M. Gearing, C. Duyckaerts, H. Yokoo, Y. Nakazato, et al. (2004)
Am. J. Pathol. 164, 2153-2161
   Abstract »    Full Text »    PDF »
S-Nitrosylation of Parkin Regulates Ubiquitination and Compromises Parkin's Protective Function.
K. K. K. Chung, B. Thomas, X. Li, O. Pletnikova, J. C. Troncoso, L. Marsh, V. L. Dawson, and T. M. Dawson (2004)
Science 304, 1328-1331
   Abstract »    Full Text »    PDF »
Exploiting Proteomics in the Discovery of Drugs That Target Mitochondrial Oxidative Damage.
B. W. Gibson (2004)
Sci. Aging Knowl. Environ. 2004, pe12
   Abstract »    Full Text »
17q-Linked Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Without Tau Mutations With Tau and {alpha}-Synuclein Inclusions.
K. C. Wilhelmsen, M. S. Forman, H. J. Rosen, L. I. Alving, J. Goldman, J. Feiger, J. V. Lee, S. K. Segall, J. H. Kramer, C. Lomen-Hoerth, et al. (2004)
Arch Neurol 61, 398-406
   Abstract »    Full Text »    PDF »
Mechanism of Toxicity in Rotenone Models of Parkinson's Disease.
T. B. Sherer, R. Betarbet, C. M. Testa, B. B. Seo, J. R. Richardson, J. H. Kim, G. W. Miller, T. Yagi, A. Matsuno-Yagi, and J. T. Greenamyre (2003)
J. Neurosci. 23, 10756-10764
   Abstract »    Full Text »    PDF »
Molecular Pathways of Neurodegeneration in Parkinson's Disease.
T. M. Dawson and V. L. Dawson (2003)
Science 302, 819-822
   Abstract »    Full Text »    PDF »
Identification and Characterization of a Novel Pyk2/Related Adhesion Focal Tyrosine Kinase-associated Protein That Inhibits {alpha}-Synuclein Phosphorylation.
T. Takahashi, H. Yamashita, Y. Nagano, T. Nakamura, H. Ohmori, H. Avraham, S. Avraham, M. Yasuda, and M. Matsumoto (2003)
J. Biol. Chem. 278, 42225-42233
   Abstract »    Full Text »    PDF »
Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies.
A. Iwata, M. Maruyama, T. Akagi, T. Hashikawa, I. Kanazawa, S. Tsuji, and N. Nukina (2003)
Hum. Mol. Genet. 12, 2625-2635
   Abstract »    Full Text »    PDF »
Oxidative Damage to Mitochondrial Complex I Due to Peroxynitrite: IDENTIFICATION OF REACTIVE TYROSINES BY MASS SPECTROMETRY.
J. Murray, S. W. Taylor, B. Zhang, S. S. Ghosh, and R. A. Capaldi (2003)
J. Biol. Chem. 278, 37223-37230
   Abstract »    Full Text »    PDF »
Neuroprotection in PD--A role for dopamine agonists?.
A.H. V. Schapira (2003)
Neurology 61, S34-42
   Full Text »
Nitration of Tau Protein Is Linked to Neurodegeneration in Tauopathies.
T. Horiguchi, K. Uryu, B. I. Giasson, H. Ischiropoulos, R. LightFoot, C. Bellmann, C. Richter-Landsberg, V. M.-Y. Lee, and J. Q. Trojanowski (2003)
Am. J. Pathol. 163, 1021-1031
   Abstract »    Full Text »    PDF »
Certain Metals Trigger Fibrillation of Methionine-oxidized {alpha}-Synuclein.
G. Yamin, C. B. Glaser, V. N. Uversky, and A. L. Fink (2003)
J. Biol. Chem. 278, 27630-27635
   Abstract »    Full Text »    PDF »
Effects of Oxidative and Nitrative Challenges on {alpha}-Synuclein Fibrillogenesis Involve Distinct Mechanisms of Protein Modifications.
E. H. Norris, B. I. Giasson, H. Ischiropoulos, and V. M.-Y. Lee (2003)
J. Biol. Chem. 278, 27230-27240
   Abstract »    Full Text »    PDF »
Nitric Oxide Triggers the Toxicity due to Glutathione Depletion in Midbrain Cultures through 12-Lipoxygenase.
S. Canals, M. J. Casarejos, S. de Bernardo, E. Rodriguez-Martin, and M. A. Mena (2003)
J. Biol. Chem. 278, 21542-21549
   Abstract »    Full Text »    PDF »
Parkin Facilitates the Elimination of Expanded Polyglutamine Proteins and Leads to Preservation of Proteasome Function.
Y. C. Tsai, P. S. Fishman, N. V. Thakor, and G. A. Oyler (2003)
J. Biol. Chem. 278, 22044-22055
   Abstract »    Full Text »    PDF »
NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
D.-C. Wu, P. Teismann, K. Tieu, M. Vila, V. Jackson-Lewis, H. Ischiropoulos, and S. Przedborski (2003)
PNAS 100, 6145-6150
   Abstract »    Full Text »    PDF »
Cocaine Abusers Have an Overexpression of alpha -Synuclein in Dopamine Neurons.
D. C. Mash, Q. Ouyang, J. Pablo, M. Basile, S. Izenwasser, A. Lieberman, and R. J. Perrin (2003)
J. Neurosci. 23, 2564-2571
   Abstract »    Full Text »    PDF »
Phosphorylated alpha -Synuclein Is Ubiquitinated in alpha -Synucleinopathy Lesions.
M. Hasegawa, H. Fujiwara, T. Nonaka, K. Wakabayashi, H. Takahashi, V. M.-Y. Lee, J. Q. Trojanowski, D. Mann, and T. Iwatsubo (2002)
J. Biol. Chem. 277, 49071-49076
   Abstract »    Full Text »    PDF »
Parkin Accumulation in Aggresomes Due to Proteasome Impairment.
E. Junn, S. S. Lee, U. T. Suhr, and M. M. Mouradian (2002)
J. Biol. Chem. 277, 47870-47877
   Abstract »    Full Text »    PDF »
Sharing signals: connecting lung epithelial cells with gap junction channels.
M. Koval (2002)
Am J Physiol Lung Cell Mol Physiol 283, L875-L893
   Abstract »    Full Text »    PDF »
Evidence for Early Cytotoxic Aggregates in Transgenic Mice for Human Transthyretin Leu55Pro.
M. M. Sousa, R. Fernandes, J. A. Palha, A. Taboada, P. Vieira, and M. J. Saraiva (2002)
Am. J. Pathol. 161, 1935-1948
   Abstract »    Full Text »    PDF »
Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays.
S. S. Sarang, T. Yoshida, R. Cadet, A. S. Valeras, R. V. Jensen, and S. R. Gullans (2002)
Physiol Genomics 11, 45-52
   Abstract »    Full Text »    PDF »
Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration.
L. Y. Marmorstein, F. L. Munier, Y. Arsenijevic, D. F. Schorderet, P. J. McLaughlin, D. Chung, E. Traboulsi, and A. D. Marmorstein (2002)
PNAS 99, 13067-13072
   Abstract »    Full Text »    PDF »
An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered alpha -Synuclein Metabolism and Oxidative Damage.
T. B. Sherer, R. Betarbet, A. K. Stout, S. Lund, M. Baptista, A. V. Panov, M. R. Cookson, and J. T. Greenamyre (2002)
J. Neurosci. 22, 7006-7015
   Abstract »    Full Text »    PDF »
Environment, Mitochondria, and Parkinson's Disease.
T. B. Sherer, R. Betarbet, and J. T. Greenamyre (2002)
Neuroscientist 8, 192-197
   Abstract »    PDF »
Tau and {alpha}-Synuclein Pathology in Amygdala of Parkinsonism-Dementia Complex Patients of Guam.
M. S. Forman, M. L. Schmidt, S. Kasturi, D. P. Perl, V. M.-Y. Lee, and J. Q. Trojanowski (2002)
Am. J. Pathol. 160, 1725-1731
   Abstract »    Full Text »    PDF »
Peroxynitrite-induced Nitration of Tyrosine Hydroxylase. IDENTIFICATION OF TYROSINES 423, 428, AND 432 AS SITES OF MODIFICATION BY MATRIX-ASSISTED LASER DESORPTION IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY AND TYROSINE-SCANNING MUTAGENESIS.
D. M. Kuhn, M. Sadidi, X. Liu, C. Kreipke, T. Geddes, C. Borges, and J. T. Watson (2002)
J. Biol. Chem. 277, 14336-14342
   Abstract »    Full Text »    PDF »
Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of alpha -Synuclein in the Nigrostriatal System.
D. Kirik, C. Rosenblad, C. Burger, C. Lundberg, T. E. Johansen, N. Muzyczka, R. J. Mandel, and A. Bjorklund (2002)
J. Neurosci. 22, 2780-2791
   Abstract »    Full Text »    PDF »
alpha -Synuclein Protects against Oxidative Stress via Inactivation of the c-Jun N-terminal Kinase Stress-signaling Pathway in Neuronal Cells.
M. Hashimoto, L. J. Hsu, E. Rockenstein, T. Takenouchi, M. Mallory, and E. Masliah (2002)
J. Biol. Chem. 277, 11465-11472
   Abstract »    Full Text »    PDF »
Formation and Removal of alpha -Synuclein Aggregates in Cells Exposed to Mitochondrial Inhibitors.
H.-J. Lee, S. Y. Shin, C. Choi, Y. H. Lee, and S.-J. Lee (2002)
J. Biol. Chem. 277, 5411-5417
   Abstract »    Full Text »    PDF »
Book Review: Iron and Parkinson's Disease.
B. Wolozin and N. Golts (2002)
Neuroscientist 8, 22-32
   Abstract »    PDF »
Neuroprotection and dopamine agonists.
A. H. V. Schapira (2002)
Neurology 58, S9-18
   Abstract »    Full Text »
Recent advances in the genetics and pathogenesis of Parkinson disease.
M. M. Mouradian (2002)
Neurology 58, 179-185
   Abstract »    Full Text »    PDF »
Membrane-bound alpha -Synuclein Has a High Aggregation Propensity and the Ability to Seed the Aggregation of the Cytosolic Form.
H.-J. Lee, C. Choi, and S.-J. Lee (2002)
J. Biol. Chem. 277, 671-678
   Abstract »    Full Text »
Selective Insolubility of {alpha}-Synuclein in Human Lewy Body Diseases Is Recapitulated in a Transgenic Mouse Model.
P. J. Kahle, M. Neumann, L. Ozmen, V. Muller, S. Odoy, N. Okamoto, H. Jacobsen, T. Iwatsubo, J. Q. Trojanowski, H. Takahashi, et al. (2001)
Am. J. Pathol. 159, 2215-2225
   Abstract »    Full Text »    PDF »
Nitration and Inactivation of Tyrosine Hydroxylase by Peroxynitrite.
B. Blanchard-Fillion, J. M. Souza, T. Friel, G. C. T. Jiang, K. Vrana, V. Sharov, L. Barron, C. Schoneich, C. Quijano, B. Alvarez, et al. (2001)
J. Biol. Chem. 276, 46017-46023
   Abstract »    Full Text »    PDF »
Exposure to Long Chain Polyunsaturated Fatty Acids Triggers Rapid Multimerization of Synucleins.
R. J. Perrin, W. S. Woods, D. F. Clayton, and J. M. George (2001)
J. Biol. Chem. 276, 41958-41962
   Abstract »    Full Text »    PDF »
In Vivo Retinal Gene Expression in Early Diabetes.
A. M. Joussen, S. Huang, V. Poulaki, K. Camphausen, W.-D. Beecken, B. Kirchhof, and A. P. Adamis (2001)
Invest. Ophthalmol. Vis. Sci. 42, 3047-3057
   Abstract »    Full Text »    PDF »
The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse.
G. P. Lim, T. Chu, F. Yang, W. Beech, S. A. Frautschy, and G. M. Cole (2001)
J. Neurosci. 21, 8370-8377
   Abstract »    Full Text »    PDF »
Induction of {alpha}-Synuclein Aggregation by Intracellular Nitrative Insult.
E. Paxinou, Q. Chen, M. Weisse, B. I. Giasson, E. H. Norris, S. M. Rueter, J. Q. Trojanowski, V. M.-Y. Lee, and H. Ischiropoulos (2001)
J. Neurosci. 21, 8053-8061
   Abstract »    Full Text »    PDF »
The Hunt for a Cure for Parkinson's Disease.
J. K. Andersen, J. Kumar, B. Srinivas, D. Kaur, M. Hsu, and S. Rajagopalan (2001)
Sci. Aging Knowl. Environ. 2001, re1-1
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)